AI Portfolio Summary
In 2026 Q1, Versant Venture Management, LLC maintained a portfolio of 8 distinct positions. The most significant new addition to the portfolio was Century Therapeutics, which now represents 19.44% of the total fund value. The fund also reduced its exposure to Monte Rosa Therapeut by 27.4%.
Total Positions
8
Quarter
2026 Q1
Top Holding
GLUE (37.0%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-8 of 8
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GLUE
Monte Rosa Ther...
|
Healthcare | 37.00% | 45.49% |
#1
Prev: #1
|
6.0 | -1,201,907 | -27.4% |
P
S
|
3,180,780 | $52,323,831 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-05 | |||
|
IPSC
Century Therape...
|
Healthcare | 19.44% | — |
#2
Prev: #—
|
9.0 | 12,166,109 | no change |
NEW
|
12,166,109 | $27,495,406 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-05 | |||
|
LENZ
Lenz Therapeuti...
|
Healthcare | 17.19% | 28.14% |
#3
1
Prev: #2
|
6.0 | no change | no change |
P
S
|
2,656,888 | $24,310,525 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-05 | |||
|
JBIO
Jade Bioscience...
|
Healthcare | 15.16% | 15.59% |
#4
1
Prev: #3
|
5.5 | no change | no change |
P
S
|
1,525,820 | $21,437,771 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-05 | |||
|
CTNM
Contineum Thera...
|
Healthcare | 5.01% | 4.11% |
#5
Prev: #5
|
3.5 | no change | no change |
P
S
|
542,628 | $7,086,722 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-05 | |||
|
CRSP
CRISPR Therapeu...
|
Healthcare | 5.01% | 5.17% |
#6
2
Prev: #4
|
3.0 | no change | no change |
P
S
|
148,831 | $7,079,891 | 2018 Q1 | 13F Filing | 2026-03-31 | 2026-05-05 | |||
|
SKYE
Skye Bioscience...
|
Healthcare | 0.87% | 1.00% |
#7
1
Prev: #6
|
1.3 | no change | no change |
P
S
|
2,007,704 | $1,233,935 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-05 | |||
|
N/A
Tempest Therape...
|
—
|
Unknown | 0.31% | 0.51% |
#8
1
Prev: #7
|
1.1 | no change | no change |
P
S
|
269,772 | $442,426 | — | 13F Filing | 2026-03-31 | 2026-05-05 |
Showing 1-8 of 8 holdings